Oracle Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-193,800
Closed -$921K 40
2022
Q1
$921K Sell
193,800
-56,200
-22% -$752K 0.18% 24
2021
Q4
$425K Buy
+250,000
New +$6M 0.06% 28
2021
Q2
Sell
-46,900
Closed -$356K 33
2021
Q1
$356K Buy
+46,900
New +$2.45M 0.05% 26

Other funds holding DMTK

Oracle Investment Management's DMTK Position: Q2 2024 in Review

Oracle Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 47,687 shares — an estimated $33.5K sold.

Oracle Investment Management first reported a position in DMTK in Q4 2020 and held it in 14 quarters. The position peaked at $36.2M in Q1 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Oracle Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Oracle Investment Management sold 47,687 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $33.5K.
  • Oracle Investment Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Oracle Investment Management's DermTech, Inc. Common Stock position peaked at $36.2M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Oracle Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.